Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05402033 · ClinicalTrials.gov registry record
Cancer Clinical Trials Financial Reimbursement Program
A clinical trial of Cancer Clinical Trials, sponsored by University of Texas Southwestern Medical Center.
- Recruiting
- Registry status
- 1,200
- Enrollment target
- 1
- Study location
NCT05402033: Recruiting study of Cancer Clinical Trials, sponsored by University of Texas Southwestern Medical Center.
NCT05402033 is a study of Cancer Clinical Trials that is actively recruiting participants, run by University of Texas Southwestern Medical Center. The registered enrollment target is 1,200 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05402033, a study of Cancer Clinical Trials, is actively recruiting participants, sponsored by University of Texas Southwestern Medical Center.
- RECRUITING
- Registry status
- 1,200 participants
- Enrollment target
- 1
- Study location
Study Summary
To implement a Financial Reimbursement and Outreach Program at clinical sites within the Harold C. Simmons Comprehensive Cancer Center; and evaluate the impact of the program on clinical trial enrollment and demographics, as well as facilitators of and barriers to program participation.
Primary Outcome
Use COST PROM to calculate the clinical trial enrollment and retention rates of the patients eligible for and participate in the Financial Reimbursement Program (FRP) versus those that decline to participate in the FRP.
Conditions Studied
Interventions
- BEHAVIORAL Survey / Interview Group
Study Locations (1)
Texas
- University of Texas Southwestern Medical Center - Dallas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,200 participants |
| Start Date | 2022-07-12 |
| Est. Completion | 2027-06-01 |
What NCT05402033 shows while recruiting
NCT05402033 is an observational study that tracks outcomes without assigning an intervention. Its 1,200 participants enrollment target places it among the larger protocols in the corpus.
The record links to 1 condition, with Cancer Clinical Trials appearing as the primary indexed condition, and to 1 intervention - of which Survey / Interview Group is the first listed.
NCT05402033 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT05402033 about?
NCT05402033 is a clinical study titled "Cancer Clinical Trials Financial Reimbursement Program". To implement a Financial Reimbursement and Outreach Program at clinical sites within the Harold C. Simmons Comprehensive Cancer Center; and evaluate the impact of the program on clinical trial enrollment and demographics, as well as facilitators of and barriers to program participation.
What is the current status of trial NCT05402033?
This trial is currently recruiting. The enrollment target is 1,200 participants. The study started on 2022-07-12. Estimated completion is 2027-06-01.
What conditions does trial NCT05402033 study?
This clinical trial studies the following conditions: Cancer Clinical Trials.
What interventions are being tested in trial NCT05402033?
The interventions under investigation include: Survey / Interview Group (BEHAVIORAL).
Who is sponsoring clinical trial NCT05402033?
This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05402033 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cancer Clinical Trials
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001987 · 1,200 participants
Genetic Studies of Insulin and Diabetes
- NCT00477100 · 1,200 participants
Biospecimen and Medical Data Collection and Tumor Biopsy in Creating Research Tissue Registry in Patients With Inflammatory or Invasive Breast Cancer
- NCT01209000 · 1,200 participants
Nephrotic Syndrome Study Network
- NCT01944332 · 1,200 participants · NA
Gamete Treatment to Correct Fertilization Failure
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI